SCHEMBL28041863

SCHEMBL28041863

FCC(CCBr)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13741513 0.77
SCHEMBL4272432 0.76
SCHEMBL726269 0.75
SCHEMBL4325166 0.74
SCHEMBL2066130 0.67 ALDH1A1 (0.30)
SCHEMBL14507897 0.67
SCHEMBL20304614 0.65
SCHEMBL799360 0.65
SCHEMBL798845 0.65
SCHEMBL8629366 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104781258-B Hydroxy-substituted imidazo [1,2-a ] pyridinecarboxamides and their use as soluble guanylate cyclase stimulators 拜耳制药股份公司 2017-09-22 CN disclosed
CN-106715426-A Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use 拜耳医药股份有限公司 2017-05-24 CN disclosed
CN-104981470-B Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use 拜耳制药股份公司 2017-04-19 CN disclosed
CN-104981470-A Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use Bayer Pharma AG 2015-10-14 CN disclosed